Evidence map›Paper›PMID 40463185›Full record

ArticlebioRxiv : the preprint server for biology2025

The Contribution of the Koniocellular Visual Pathway to Aversive Learning in Human Visual Cortex.

Katherine J McCain, Nathan M Petro, Andreas Keil

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Katherine J McCainDepartment of Psychology, University of Florida, Gainesville, Florida 32603.
Nathan M PetroInstitute for Human Neuroscience, Boys Town National Research Hospital, Boys Town, Nebraska 68010.
Andreas KeilDepartment of Psychology, University of Florida, Gainesville, Florida 32603.

Funding

Ding R01 Administrative SupplementR01MH125615 · NIMH · UNIVERSITY OF FLORIDA · PI DING, MINGZHOU, KEIL, ANDREAS · 2021 to 2025
$2.5M
NIMH NIH HHS R01 MH125615
6 · The paper itself

Abstract

The present study examined the contribution of the koniocellular retino-geniculate visual pathway to the electrocortical amplification of threat cues in human visual cortex using an aversive conditioning task. The task involved tritan stimuli, which are thought to convey visual information through S-cone signals that project to regions along the koniocellular pathway (tritan condition) and achromatic stimuli that preferentially activate luminance channels (luminance condition). Steady-state visual evoked potential (ssVEPs) responses to the conditioned threat (CS+) and safety cues (CS-) in each condition were analyzed using a non-parametric Bayesian bootstrapped approach. Results showed that the tritan and luminance conditions exhibited greater ssVEP responses to the CS+ compared to the CS- stimuli in occipital sensors early into the trial (0 ms - 1000 ms; logBF10 > 2, decisive support). In addition to these early conditioning effects, a late conditioning effect was observed (1500 ms - 2500 ms) in the tritan condition that emerged in bilateral anterior sensors (logBF10 > 2). To further examine the tritan contribution to aversive learning, transitive Bayes factors were computed to compare the magnitude of the conditioning effects across conditions. Transitive Bayes factors showed that the early conditioning effect was larger in the luminance condition compared to the tritan condition (logBF10 > 2). Furthermore, the late conditioning effect remained larger in the tritan condition compared to the luminance condition (logBF10 > 2). Our findings suggest that both the koniocellular visual pathway and luminance channels play a role in the electrocortical amplification of threat signals in human visual cortex.

Identifiers

PMID40463185
PMCPMC12132362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.